110 related articles for article (PubMed ID: 26104259)
1. Expectant management of severe preeclampsia with severe fetal growth restriction in the second trimester.
Aoki S; Toma R; Kurasawa K; Okuda M; Takahashi T; Hirahara F
Pregnancy Hypertens; 2014 Jan; 4(1):81-6. PubMed ID: 26104259
[TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction.
Belghiti J; Kayem G; Tsatsaris V; Goffinet F; Sibai BM; Haddad B
Am J Obstet Gynecol; 2011 Nov; 205(5):465.e1-6. PubMed ID: 21889120
[TBL] [Abstract][Full Text] [Related]
3. Management of preeclampsia.
Dekker GA
Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
[TBL] [Abstract][Full Text] [Related]
4. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?
Chammas MF; Nguyen TM; Li MA; Nuwayhid BS; Castro LC
Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of fetal growth restriction complicated later by preeclampsia.
Mitani M; Matsuda Y; Makino Y; Akizawa Y; Ohta H
J Obstet Gynaecol Res; 2009 Oct; 35(5):882-7. PubMed ID: 20149036
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of expectant management of severe preeclampsia and preeclampsia superimposed on chronic hypertension before 34 weeks gestation.
Hoshino A; Obata S; Tochio A; Seki K; Miyagi E; Aoki S
Pregnancy Hypertens; 2019 Jan; 15():177-180. PubMed ID: 30825918
[TBL] [Abstract][Full Text] [Related]
7. The "weight" of fetal growth restriction in 437 hypertensive pregnancies.
Tranquilli AL; Giannubilo SR
Arch Gynecol Obstet; 2004 Dec; 270(4):214-6. PubMed ID: 12942263
[TBL] [Abstract][Full Text] [Related]
8. More Maternal Vascular Malperfusion and Chorioamnionitis in Placentas After Expectant Management vs. Immediate Delivery in Fetal Growth Restriction at (Near) Term: A Further Analysis of the DIGITAT Trial.
Feenstra ME; Schoots MH; Plösch T; Prins JR; Scherjon SA; Timmer A; van Goor H; Gordijn SJ
Front Endocrinol (Lausanne); 2019; 10():238. PubMed ID: 31105647
[No Abstract] [Full Text] [Related]
9. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD; Sotiriadis A; Kaihura C; Nicolaides KH; Sattar N
Clin Sci (Lond); 2008 Oct; 115(7):219-24. PubMed ID: 18211260
[TBL] [Abstract][Full Text] [Related]
10. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction.
Kovo M; Schreiber L; Ben-Haroush A; Gold E; Golan A; Bar J
Prenat Diagn; 2012 Jul; 32(7):632-7. PubMed ID: 22565848
[TBL] [Abstract][Full Text] [Related]
11. Expectant management in pregnant women with early and severe preeclampsia and concomitant risk factors.
Astudillo R; Suy A; Alijotas-Reig J; Carreras E; Llurba E; Goya M; Higueras T; Cabero L
Pregnancy Hypertens; 2013 Oct; 3(4):235-41. PubMed ID: 26103802
[TBL] [Abstract][Full Text] [Related]
12. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?
Haddad B; Kayem G; Deis S; Sibai BM
Am J Obstet Gynecol; 2007 Mar; 196(3):237.e1-5. PubMed ID: 17346535
[TBL] [Abstract][Full Text] [Related]
13. First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction.
Valdés ER; Lattes KA; Muñoz HS; Barja PY; Papapietro KV
Gynecol Obstet Invest; 2011; 72(3):152-6. PubMed ID: 21912074
[TBL] [Abstract][Full Text] [Related]
14. A protocol for managing severe preeclampsia in the second trimester.
Sibai BM; Akl S; Fairlie F; Moretti M
Am J Obstet Gynecol; 1990 Sep; 163(3):733-8. PubMed ID: 2403154
[TBL] [Abstract][Full Text] [Related]
15. An analysis of expectant management in women with early-onset preeclampsia in China.
Chen Q; Shen F; Gao YF; Zhao M
J Hum Hypertens; 2015 Jun; 29(6):379-84. PubMed ID: 25339294
[TBL] [Abstract][Full Text] [Related]
16. [The predictive value of plasma fibronectin concentration on fetal growth retardation and preeclampsia at earlier stage of the third trimester].
Xiong G; Wang Z; Yu Q
Zhonghua Fu Chan Ke Za Zhi; 2001 Dec; 36(12):734-7. PubMed ID: 16136894
[TBL] [Abstract][Full Text] [Related]
17. Fetal growth restriction as a diagnostic criterion for preeclampsia.
Obata S; Toda M; Tochio A; Hoshino A; Miyagi E; Aoki S
Pregnancy Hypertens; 2020 Jul; 21():58-62. PubMed ID: 32413588
[TBL] [Abstract][Full Text] [Related]
18. OS078. Fetal growth restriction: A marker of severity of early-onset pre-eclampsia?
Khalil A; Suff N; Grande A; David A; Khalil A
Pregnancy Hypertens; 2012 Jul; 2(3):220. PubMed ID: 26105292
[TBL] [Abstract][Full Text] [Related]
19. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center.
Gaugler-Senden IP; Huijssoon AG; Visser W; Steegers EA; de Groot CJ
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):216-21. PubMed ID: 16359774
[TBL] [Abstract][Full Text] [Related]
20. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation.
Haddad B; Deis S; Goffinet F; Paniel BJ; Cabrol D; Siba BM
Am J Obstet Gynecol; 2004 Jun; 190(6):1590-5; discussion 1595-7. PubMed ID: 15284743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
